Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
05/1999
05/14/1999WO1999022728A1 Methods and compositions for regulation of 5-alpha reductase activity
05/14/1999WO1999022726A1 N,n'-bis(sulfonyl)hydrazines useful as antineoplastic agents
05/14/1999WO1999022722A2 Use of macrolides for the treatment of cancer and macular degeneration
05/14/1999WO1999007692A3 New epothilone derivatives, method for producing same and their pharmaceutical use
05/14/1999WO1999005269A8 Transcriptional silencer protein nrf
05/14/1999WO1999004265A8 Cancer associated nucleic acids and polypeptides
05/14/1999WO1999002183A3 A method of inducing a ctl response
05/14/1999WO1999001764A3 METHOD FOR DETERMINING GnRH RECEPTORS
05/14/1999WO1998033904A3 An antisense oligonucleotide preparation method
05/14/1999WO1998014593A9 Human telomerase catalytic subunit
05/14/1999CA2309175A1 Therapeutically active compounds based on indazole bioisostere replacement of catechol in pde4 inhibitors
05/14/1999CA2308575A1 Hyperthermic inducible expression vectors for gene therapy and methods of use thereof
05/14/1999CA2308438A1 Method and compositions for inhibiting angiogenesis and treating cancer
05/14/1999CA2308385A1 Antimutagenic compositions for treatment and prevention of photodamage to skin
05/14/1999CA2308112A1 Caspase-14 polypeptides
05/14/1999CA2308091A1 Inducible phosphofructokinase and the warburg effect
05/14/1999CA2308029A1 Reagents and methods useful for detecting diseases of the breast
05/14/1999CA2307850A1 Use of macrolides for the treatment of cancer and macular degeneration
05/14/1999CA2307770A1 Novel carboxylic acid derivatives which carry amide side chains, production of said carboxylic acid derivatives and their use as endothelin receptor antagonists
05/14/1999CA2307191A1 Radioactive embolizing compositions
05/14/1999CA2307190A1 Methods for treating prostate tumors using radioactive compositions
05/14/1999CA2307166A1 Methods and compositions comprising glycoprotein glycoforms
05/14/1999CA2276685A1 Suppressor of cytokine signaling
05/12/1999EP0915086A1 Phenylsulfonamide derivatives
05/12/1999EP0914830A1 Neovascularization inhibitor containing tissue factor pathway inhibitor
05/12/1999EP0914459A2 Adenoviral mediated gene transfer in adipocytes and related implants
05/12/1999EP0914456A1 Gene expression in monocytes and macrophages
05/12/1999EP0914448A1 Lipid kinase
05/12/1999EP0914435A1 Hybrid interferon compositions and methods of use
05/12/1999EP0914432A2 Secreted proteins and polynucleotides encoding them
05/12/1999EP0914430A2 Polynucleotides from human fetal brain encoding secreted proteins
05/12/1999EP0914346A1 THERAPEUTIC MULTISPECIFIC COMPOUNDS COMPRISED OF ANTI-FC$g(a) RECEPTOR ANTIBODIES
05/12/1999EP0914345A1 Antibodies binding to monocyte chemoattractant protein 1 (mcp-1) receptor (ccr2)
05/12/1999EP0914341A1 Antagonists of intestinotrophic glp-2 peptides
05/12/1999EP0914340A1 hGH-RH(1-29)NH 2? ANALOGUES HAVING ANTAGONISTIC ACTIVITY
05/12/1999EP0914336A2 Secreted proteins
05/12/1999EP0914334A1 Process and intermediates for the synthesis of lhrh antagonists
05/12/1999EP0914325A1 Modulators of the function of fas receptors and other proteins
05/12/1999EP0914155A1 Monoclonal antibodies specific for the extracellular domain of prostate specific membrane antigen
05/12/1999EP0914142A1 Peptides with increased binding affinity for hla molecules
05/12/1999EP0914135A1 Use of protein kinase c inhibitors to enhance the clinical efficacy of oncolytic agents and radiation therapy
05/12/1999EP0914116A1 Compositions comprising conjugates of cis-docosahexaenoic acid and taxotere
05/12/1999EP0914111A2 Method for the prevention and treatment of cachexia and anorexia
05/12/1999EP0914102A1 Compositions and methods for treating or preventing diseases of body passageways
05/12/1999EP0914043A1 Implantable agarose-collagen beads containing cells which produce a diffusible biological product, and uses thereof
05/12/1999EP0739354B1 Compositions and methods using unbound mpl receptor for stimulating platelet production
05/12/1999EP0733067B1 N-terminally chemically modified protein compositions and methods
05/12/1999EP0668923B1 Monoclonal antibody
05/12/1999EP0481000B1 Receptors for fibroblast growth factors
05/12/1999CN1216549A Antipathogenic peptides and compositions comprising them
05/12/1999CN1216545A Farnesyl transferase inhibitors
05/12/1999CN1216544A Novel N-7-heterocyclyl pyrrolo [2,3-D] pyridines and their use
05/12/1999CN1216256A Galenic preparation for prevention and treatment of hepatocarcinoma
05/12/1999CN1043344C New heterocyclic compounds, preparing method, pharmaceutical composition and use
05/11/1999US5902830 Lowering plasma cholesterol levels
05/11/1999US5902822 Novel antitumor derivatives for use as antitumor agents
05/11/1999US5902817 2-sulfinyl or sulfonylpentandioic acids; inhibitors of n-acetylated alpha-linked acidic dipeptidase; glutamate abnormalities; prostates; antiepileptic and -ischemic agents; strokes; analgesics; nervous sytem injuries;
05/11/1999US5902794 Camp derivatives, one is selective for site 1 of a type ii camp dependent protein kinase and the other is selective for site 2 of type i or ii camp dependent protein kinase, having a synergistic inhibitory effect on cancer cell growth
05/11/1999US5902791 Metalloproteinase inhibitors
05/11/1999US5902790 Pharmaceutical angiostatic dipeptide compositions and method of use thereof
05/11/1999US5902788 For cutaneous melanomas
05/11/1999US5902610 Formulations and methods of use of 2,2'-dithio-bis-ethane sulfonate
05/11/1999US5902583 Genetic induction of receptors for targeted radiotherapy
05/07/1999CA2220621A1 Transdermal delivery system
05/06/1999WO1999022243A1 148 human secreted proteins
05/06/1999WO1999022000A1 Inhibitor protein of the wnt signal pathway
05/06/1999WO1999021998A1 Wnt-1 induced secreted polypeptides: wisp-1, -2 and -3
05/06/1999WO1999021862A1 Sarcodictyin and eleutherobin useful for stabilising microtubules
05/06/1999WO1999021845A2 4-aminothiazole derivatives, their preparation and their use as inhibitors of cyclin-dependent kinases
05/06/1999WO1999021567A1 Pharmaceutical compositions for oral administration of molecular iodine
05/06/1999WO1999021557A1 Antagonists of gonadotropin releasing hormone
05/06/1999WO1999021553A1 Antagonists of gonadotropin releasing hormone
05/06/1999WO1999013920A3 Method for treating proliferative diseases by therapy
05/06/1999WO1999012963A3 Cysteine rich receptors: trail
05/06/1999WO1999010516A3 Methods and compositions for therapies using genes encoding secreted proteins such as interferon-beta
05/06/1999WO1999009164A9 Coding sequence haplotypes of the human brca2 gene
05/06/1999WO1999008729A9 Loading and release of water-insoluble drugs
05/06/1999EP0913471A2 Cdna clone HNEAA81 that encodes a human 7-transmembrane receptor
05/06/1999EP0912741A2 T-cell selective interleukin-4 agonists
05/06/1999EP0912740A1 Rantes homolog from prostate
05/06/1999EP0912738A2 Antigen binding fragments that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for the prophylaxis and detection of cancers
05/06/1999EP0912735A2 Secreted proteins and polynucleotides encoding them
05/06/1999EP0912731A2 Secreted proteins
05/06/1999EP0912729A1 INHIBITION OF CHRONIC MYELOGENOUS LEUKEMIC CELL GROWTH BY LIPOSOMAL-ANTISENSE OLIGODEOXY-NUCLEOTIDES TARGETING TO Grb2 OR Crk1
05/06/1999EP0912723A1 Highly productive packaging lines
05/06/1999EP0912600A2 Peptidomimetic inhibitors of cathepsin d and plasmepsins i and ii
05/06/1999EP0912584A2 New bis-platinum complexes with polyamine ligands as antitumor agents
05/06/1999EP0912573A1 Camptothecin-skeleton compounds isolated from mappia foetida and the use thereof as syntones for novel medicaments as well as therapeutical agents
05/06/1999EP0912572A1 Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors
05/06/1999EP0912571A2 Naphthyridines which affect il-4 and g-csf
05/06/1999EP0912570A1 Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors
05/06/1999EP0912560A1 Indole derivatives for the treatment of osteoporosis
05/06/1999EP0912559A1 Fused heterocyclic compounds as protein tyrosine kinase inhibitors
05/06/1999EP0912558A1 Substituted indazole derivatives and their use as phosphodiesterase (pde) type iv and tumor necrosis factor (tnf) inhibitors
05/06/1999EP0912551A1 Somatostatin agonists and antagonists
05/06/1999EP0912535A1 Conjugates of cis-docosahexaenoic acid and paclitaxel
05/06/1999EP0912521A1 Substituted indazole derivatives and their use as inhibitors phosphodiesterase (pde) type iv and the production of tumor necrosis factor (tnf)
05/06/1999EP0912518A1 Substituted pyridines as selective cyclooxygenase-2 inhibitors
05/06/1999EP0912509A1 Distamycin derivatives, process for preparing them, and their use as antitumor and antiviral agents
05/06/1999EP0912496A1 Inhibition of matrix metalloproteases by acetylene containing compounds
1 ... 1967 1968 1969 1970 1971 1972 1973 1974 1975 1976 1977 1978 1979 1980 1981 1982 1983 1984 1985 1986 1987 ... 2211